RVP vs. TELA, GUTS, NVNO, APYX, NSPR, SRTS, MDAI, CTSO, ZYXI, and HYPR
Should you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include TELA Bio (TELA), Fractyl Health (GUTS), enVVeno Medical (NVNO), Apyx Medical (APYX), InspireMD (NSPR), Sensus Healthcare (SRTS), Spectral AI (MDAI), Cytosorbents (CTSO), Zynex (ZYXI), and Hyperfine (HYPR). These companies are all part of the "medical equipment" industry.
Retractable Technologies vs. Its Competitors
Retractable Technologies (NYSE:RVP) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment.
Retractable Technologies has higher earnings, but lower revenue than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.
7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 94.3% of TELA Bio shares are held by institutional investors. 57.1% of Retractable Technologies shares are held by company insiders. Comparatively, 4.7% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Retractable Technologies has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500.
Retractable Technologies has a net margin of -41.11% compared to TELA Bio's net margin of -61.00%. Retractable Technologies' return on equity of -17.15% beat TELA Bio's return on equity.
TELA Bio has a consensus target price of $7.25, suggesting a potential upside of 240.38%. Given TELA Bio's stronger consensus rating and higher possible upside, analysts plainly believe TELA Bio is more favorable than Retractable Technologies.
In the previous week, Retractable Technologies and Retractable Technologies both had 1 articles in the media. Retractable Technologies' average media sentiment score of 1.00 beat TELA Bio's score of 0.00 indicating that Retractable Technologies is being referred to more favorably in the media.
Summary
Retractable Technologies beats TELA Bio on 9 of the 15 factors compared between the two stocks.
Get Retractable Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Retractable Technologies Competitors List
Related Companies and Tools
This page (NYSE:RVP) was last updated on 7/20/2025 by MarketBeat.com Staff
